Stock chart
Ticker: PE Exchange: NYS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2020-08-20 2020-08-20 S Sale

Sheffield Bryan

See Remarks

Executive Director
300,000 -3.4%
11.46
USD 3,438,000
300,000 -3.4% 11.46 USD 3,438,000
2020-08-20 2020-08-19 S Sale

Sheffield Bryan

See Remarks

Executive Director
300,000 -3.3%
12.00
USD 3,600,000
300,000 -3.3% 12.00 USD 3,600,000
2020-08-20 2020-08-18 S Sale

Sheffield Bryan

See Remarks

Executive Director
300,000 -3.2%
12.12
USD 3,636,000
300,000 -3.2% 12.12 USD 3,636,000
2020-08-07 2020-08-07 S Sale

Roberts Colin

See Remarks

Officer
30,000 -9.7%
11.14
USD 334,200
30,000 -9.7% 11.14 USD 334,200
2020-08-07 2020-08-07 S Sale

Dalton Ryan

See Remarks

Officer
60,000 -12.6%
11.14
USD 668,400
60,000 -12.6% 11.14 USD 668,400
2020-03-09 2020-03-06 B Purchase

ALAMEDDINE A R

Non-Executive Director
2,000 +1.4%
11.25
USD 22,500
2,000 +1.4% 11.25 USD 22,500
2020-03-09 2020-03-06 B Purchase

Brokmeyer Ron

Non-Executive Director
1,800 +6.2%
11.15
USD 20,070
1,800 +6.2% 11.15 USD 20,070
2020-03-09 2020-03-06 B Purchase

Windlinger Jerry

Non-Executive Director
1,618 +4.8%
11.32
USD 18,316
1,618 +4.8% 11.32 USD 18,316
2020-03-09 2020-03-05 B Purchase

ALAMEDDINE A R

Non-Executive Director
1,000 +0.7%
12.60
USD 12,600
1,000 +0.7% 12.60 USD 12,600
2020-03-04 2020-03-03 B Purchase

Brokmeyer Ron

Non-Executive Director
1,000 +3.5%
12.70
USD 12,700
1,000 +3.5% 12.70 USD 12,700
2020-02-28 2020-02-27 B Purchase

ALAMEDDINE A R

Non-Executive Director
10,000 +7.6%
13.10
USD 131,000
10,000 +7.6% 13.10 USD 131,000
2019-12-06 2019-12-06 S Sale

Roberts Colin

See Remarks

Officer
10,000 -3.7%
16.36
USD 163,600
10,000 -3.7% 16.36 USD 163,600
2019-12-06 2019-12-05 S Sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
316,700 -3.6%
15.63
USD 4,950,021
316,700 -3.6% 15.63 USD 4,950,021
2019-12-02 2019-11-29 B Purchase

Brokmeyer Ron

Non-Executive Director
5,000 +28.2%
14.95
USD 74,750
5,000 +28.2% 14.95 USD 74,750
2019-06-06 2019-06-05 B Purchase

Windlinger Jerry

1,985 +6.3%
17.50
USD 34,738
1,985 +6.3% 17.50 USD 34,738
2019-05-22 2019-05-20 S Sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
100,000 -1.1%
20.24
USD 2,024,210
100,000 -1.1% 20.24 USD 2,024,210
2019-04-12 2019-04-12 S Sale

Roberts Colin

See Remarks

3,000 -1.1%
20.00
USD 60,000
3,000 -1.1% 20.00 USD 60,000
2019-03-06 2019-03-05 S Sale

Roberts Colin

See Remarks

3,500 -1.3%
18.73
USD 65,559
3,500 -1.3% 18.73 USD 65,559
2019-03-01 2019-03-01 S Sale

Hinson Mike

See Remarks

Officer
41,727 -9.5%
18.43
USD 769,029
41,727 -9.5% 18.43 USD 769,029
2019-03-01 2019-02-28 S Sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
725,000 -7.5%
18.25
USD 13,233,208
725,000 -7.5% 18.25 USD 13,233,208
2018-12-06 2018-12-04 B Purchase

Windlinger Jerry

Non-Executive Director
3,193 +16.1%
19.94
USD 63,668
3,193 +16.1% 19.94 USD 63,668
2018-12-04 2018-12-04 B Purchase

Brokmeyer Ron

Non-Executive Director
1,000 +6.0%
19.99
USD 19,990
1,000 +6.0% 19.99 USD 19,990
2018-12-03 2018-11-30 B Purchase

Brokmeyer Ron

Non-Executive Director
3,000 +21.9%
20.30
USD 60,900
3,000 +21.9% 20.30 USD 60,900
2018-12-03 2018-11-30 B Purchase

ALAMEDDINE A R

Non-Executive Director
1,000 +0.8%
20.00
USD 20,000
1,000 +0.8% 20.00 USD 20,000
2018-11-27 2018-11-27 B Purchase

ALAMEDDINE A R

Non-Executive Director
5,000 +4.3%
21.10
USD 105,499
5,000 +4.3% 21.10 USD 105,499
2018-09-05 2018-09-04 B Purchase

Desai Hemang

Non-Executive Director
1,000 +50.0%
27.32
USD 27,320
1,000 +50.0% 27.32 USD 27,320
2018-08-30 2018-08-28 S Sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
2,500,000 -21.7%
28.15
USD 70,375,000
2,500,000 -21.7% 28.15 USD 70,375,000
2018-08-24 2018-08-24 S Sale

Hinson Mike

See Remarks

Officer
13,328 -3.2%
28.75
USD 383,180
13,328 -3.2% 28.75 USD 383,180
2018-08-10 2018-08-10 S Sale

Hinson Mike

See Remarks

Officer
250,000 -37.7%
30.24
USD 7,560,000
250,000 -37.7% 30.24 USD 7,560,000
2018-06-29 2018-06-27 PS Planned sale

Roberts Colin

See Remarks

Officer
10,000 -4.3%
30.21
USD 302,100
10,000 -4.3% 30.21 USD 302,100
2018-05-17 2018-05-15 PS Planned sale

Roberts Colin

See Remarks

Officer
10,000 -3.9%
31.59
USD 315,900
10,000 -3.9% 31.59 USD 315,900
2018-05-10 2018-05-08 S Sale

Hinson Mike

See Remarks

Officer
41,681 -9.0%
31.95
USD 1,331,708
41,681 -9.0% 31.95 USD 1,331,708
2018-05-10 2018-05-08 S Sale

Gallagher Matthew

See Remarks

Executive Director
142,971 -19.1%
31.77
USD 4,542,189
142,971 -19.1% 31.77 USD 4,542,189
2018-05-10 2018-05-08 S Sale

Dalton Ryan

See Remarks

Officer
60,742 -15.4%
31.77
USD 1,929,773
60,742 -15.4% 31.77 USD 1,929,773
2018-04-04 2018-04-02 PS Planned sale

Roberts Colin

See Remarks

Officer
7,500 -2.9%
28.29
USD 212,175
7,500 -2.9% 28.29 USD 212,175
2018-03-02 2018-03-01 B Purchase

Windlinger Jerry

3,000 +26.5%
25.48
USD 76,440
3,000 +26.5% 25.48 USD 76,440
2018-03-01 2018-03-01 B Purchase

Smith David Henry

2,000 +5.5%
25.35
USD 50,700
2,000 +5.5% 25.35 USD 50,700
2018-02-28 2018-02-28 B Purchase

Brokmeyer Ron

Non-Executive Director
2,000 +17.1%
25.66
USD 51,320
2,000 +17.1% 25.66 USD 51,320
2018-02-28 2018-02-27 S Sale

Roberts Colin

See Remarks

Officer
10,000 -3.7%
26.14
USD 261,400
10,000 -3.7% 26.14 USD 261,400
2018-02-28 2018-02-27 B Purchase

ALAMEDDINE A R

Non-Executive Director
10,000 +9.8%
25.99
USD 259,900
10,000 +9.8% 25.99 USD 259,900
2018-02-26 2018-02-26 B Purchase

Sheffield Bryan

See Remarks

Executive Director Large shareholder
189,500 +1.7%
26.34
USD 4,991,430
189,500 +1.7% 26.34 USD 4,991,430
2017-06-02 2017-06-01 S Sale

Roberts Colin

See Remarks

3,400 -1.5%
30.00
USD 102,000
3,400 -1.5% 30.00 USD 102,000
2017-05-19 2017-05-17 B Purchase

ALAMEDDINE A R

Non-Executive Director
1,600 +1.7%
31.65
USD 50,632
1,600 +1.7% 31.65 USD 50,632
2017-05-19 2017-05-17 B Purchase

ALAMEDDINE A R

Non-Executive Director
1,900 +2.0%
31.65
USD 60,128
1,900 +2.0% 31.65 USD 60,128
2017-05-12 2017-05-11 S Sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
837,500 -6.9%
31.45
USD 26,339,375
837,500 -6.9% 31.45 USD 26,339,375
2017-05-12 2017-05-10 S Sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
850,000 -6.6%
31.40
USD 26,690,000
850,000 -6.6% 31.40 USD 26,690,000
2017-05-12 2017-05-10 S Sale

Dalton Ryan

See Remarks

Officer
30,000 -8.3%
32.56
USD 976,800
30,000 -8.3% 32.56 USD 976,800
2017-05-02 2017-05-01 PS Planned sale

Roberts Colin

See Remarks

Officer
3,000 -1.3%
29.56
USD 88,680
3,000 -1.3% 29.56 USD 88,680
2017-03-31 2017-03-31 PS Planned sale

Roberts Colin

See Remarks

15,598 -6.2%
32.10
USD 500,696
15,598 -6.2% 32.10 USD 500,696
2017-03-02 2017-03-01 B Purchase

ALAMEDDINE A R

Non-Executive Director
3,500 +3.9%
30.94
USD 108,290
3,500 +3.9% 30.94 USD 108,290
2017-03-02 2017-02-28 B Purchase

Gallagher Matthew

See remarks

1,270 +0.2%
30.44
USD 38,659
1,270 +0.2% 30.44 USD 38,659
2017-03-02 2017-02-28 B Purchase

Gallagher Matthew

See remarks

31,715 +5.0%
30.19
USD 957,476
31,715 +5.0% 30.19 USD 957,476
2017-03-02 2017-02-28 B Purchase

Windlinger Jerry

3,000 +112.5%
30.35
USD 91,050
3,000 +112.5% 30.35 USD 91,050
2016-12-09 2016-12-07 PS Planned sale

Hinson Mike

See Remarks

Officer
25,000 -5.6%
36.05
USD 901,250
25,000 -5.6% 36.05 USD 901,250
2016-11-23 2016-11-21 PS Planned sale

Hinson Mike

See Remarks

Officer
25,000 -5.3%
36.18
USD 904,500
25,000 -5.3% 36.18 USD 904,500
2016-11-18 2016-11-18 S Sale

Dalton Ryan

See Remarks

Officer
12,700 -5.1%
34.90
USD 443,230
12,700 -5.1% 34.90 USD 443,230
2016-11-18 2016-11-18 S Sale

Roberts Colin

Vice President-General Counsel

Officer
5,000 -2.1%
34.92
USD 174,600
5,000 -2.1% 34.92 USD 174,600
2016-11-18 2016-11-17 B Purchase

ALAMEDDINE A R

Non-Executive Director
8,000 +9.8%
34.75
USD 278,000
8,000 +9.8% 34.75 USD 278,000
2016-11-18 2016-11-17 S Sale

Dalton Ryan

See Remarks

Officer
7,300 -2.9%
35.11
USD 256,303
7,300 -2.9% 35.11 USD 256,303
2016-11-17 2016-11-17 PS Planned sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
28,676 -0.2%
34.66
USD 993,910
28,676 -0.2% 34.66 USD 993,910
2016-11-17 2016-11-17 PS Planned sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
33,824 -0.3%
35.38
USD 1,196,693
33,824 -0.3% 35.38 USD 1,196,693
2016-11-17 2016-11-16 PS Planned sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
113,806 -0.9%
34.73
USD 3,952,482
113,806 -0.9% 34.73 USD 3,952,482
2016-11-17 2016-11-15 PS Planned sale

Sheffield Bryan

See Remarks

Executive Director Large shareholder
136,194 -1.0%
34.95
USD 4,759,980
136,194 -1.0% 34.95 USD 4,759,980
2016-11-09 2016-11-07 PS Planned sale

Hinson Mike

See Remarks

Officer
25,000 -5.0%
34.05
USD 851,250
25,000 -5.0% 34.05 USD 851,250
2016-10-24 2016-10-21 PS Planned sale

Hinson Mike

See Remarks

Officer
25,000 -4.8%